trending Market Intelligence /marketintelligence/en/news-insights/trending/pilyjaxddt_oxuwzfg3kiq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

RenovaCare appoints board chairman

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


RenovaCare appoints board chairman

RenovaCare Inc. appointed Harmel Rayat, a majority stockholder, as board chairman.

Rayat is an entrepreneur-investor, whose portfolio includes class A commercial properties in the U.S. and Canada. He has invested nearly $6 million in RenovaCare and its stem cell spray technologies.

New York-based RenovaCare is a development-stage company, which focuses on the acquisition, research, development and commercialization of autologous cellular therapies for use in medical and aesthetic applications.